{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:34:26Z","timestamp":1780572866735,"version":"3.54.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016168","name":"Ludwig Boltzmann Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajpath.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:19:53Z","timestamp":1765592393000},"page":"745-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeting Skeletal Muscle in Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-6458","authenticated-orcid":false,"given":"Christopher","family":"Dostal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6410-8858","authenticated-orcid":false,"given":"Johanna","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Antunes Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Fischlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8932-4674","authenticated-orcid":false,"given":"Jessica","family":"Marksteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-9028","authenticated-orcid":false,"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-0058","authenticated-orcid":false,"given":"Dietmar","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Hilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-614X","authenticated-orcid":false,"given":"Klaus","family":"Kratochwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-7202","authenticated-orcid":false,"given":"Bruno K.","family":"Podesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-1998","authenticated-orcid":false,"given":"Attila","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.11.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)82437-0","article-title":"Molecular genetics of Duchenne and Becker muscular dystrophy","volume":"117","author":"Darras","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2025.11.002_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0960-8966(93)90018-F","article-title":"Duchenne muscular dystrophy--Meryon's disease","volume":"3","author":"Emery","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2025.11.002_bib3","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2025.11.002_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/path.4689","article-title":"Divergent impact of toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy","volume":"239","author":"Mojumdar","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib5","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.3390\/ijms24108497","article-title":"Inflammasome activity in the skeletal muscle and heart of rodent models for Duchenne muscular dystrophy","volume":"24","author":"Onodi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.11.002_bib6","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.3390\/ijms251910393","article-title":"Macrophages in the context of muscle regeneration and Duchenne muscular dystrophy","volume":"25","author":"Hernandez-Torres","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.11.002_bib7","article-title":"Inference of immune cell composition on the expression profiles of mouse tissue","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.11.002_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s44303-024-00058-8","article-title":"Evaluation of the redox alteration in Duchenne muscular dystrophy model mice using in vivo DNP-MRI","volume":"2","author":"Eto","year":"2024","journal-title":"NPJ Imaging"},{"key":"10.1016\/j.ajpath.2025.11.002_bib9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in Duchenne muscular dystrophy\u2013exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2025.11.002_bib10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3389\/fphys.2020.00690","article-title":"Mitochondrial dysfunction is an early consequence of partial or complete dystrophin loss in mdx mice","volume":"11","author":"Moore","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib11","doi-asserted-by":"crossref","first-page":"H128","DOI":"10.1152\/ajpheart.00552.2016","article-title":"Lifelong quercetin enrichment and cardioprotection in Mdx\/Utrn+\/- mice","volume":"312","author":"Ballmann","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2013.213","article-title":"Treatment of dystrophin cardiomyopathies","volume":"11","author":"Finsterer","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib13","doi-asserted-by":"crossref","first-page":"H1969","DOI":"10.1152\/ajpheart.00489.2007","article-title":"The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice","volume":"293","author":"Williams","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.20517\/jtgg.2024.29","article-title":"Duchenne muscular dystrophy: diagnosis and perspective of treatment","volume":"8","author":"Corrado","year":"2024","journal-title":"J Transl Genet Genomics"},{"key":"10.1016\/j.ajpath.2025.11.002_bib15","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s13311-023-01423-y","article-title":"Evolving therapeutic options for the treatment of Duchenne muscular dystrophy","volume":"20","author":"D'Ambrosio","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ajpath.2025.11.002_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.514","article-title":"Efficacy of sodium-glucose cotransporter-2 inhibitors in patients with acute myocardial infarction: a meta-analysis of randomised controlled trials","volume":"7","author":"Ahmed","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.ajpath.2025.11.002_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.11.002_bib19","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/jcsm.13350","article-title":"Improved endurance capacity of diabetic mice during SGLT2 inhibition: role of AICARP, an AMPK activator in the soleus","volume":"14","author":"Nakamura","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ajpath.2025.11.002_bib20","doi-asserted-by":"crossref","first-page":"H117","DOI":"10.1152\/ajpheart.00100.2021","article-title":"Treatments for skeletal muscle abnormalities in heart failure: sodium-glucose transporter 2 and ketone bodies","volume":"322","author":"Takada","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/ijms26041670","article-title":"Anti-inflammatory effects of SGLT2 inhibitors: focus on macrophages","volume":"26","author":"Rykova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.11.002_bib22","doi-asserted-by":"crossref","first-page":"H418","DOI":"10.1152\/ajpheart.00729.2023","article-title":"Empagliflozin treatment rescues abnormally reduced Na(+) currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice","volume":"326","author":"Sauer","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib23","doi-asserted-by":"crossref","first-page":"H680","DOI":"10.1152\/ajpheart.00363.2025","article-title":"The sodium\/glucose cotransporter 2 inhibitor empagliflozin is a pharmacological chaperone of cardiac Na(v)1.5 channels","volume":"329","author":"Sauer","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12997\/jla.2022.11.1.1","article-title":"SGLT2 inhibitors and ketone metabolism in heart failure","volume":"11","author":"Saucedo-Orozco","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.ajpath.2025.11.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1291450","article-title":"The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy","volume":"10","author":"Su","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fcvm.2019.00186","article-title":"SGLT2 inhibitors play a salutary role in heart failure via modulation of the mitochondrial function","volume":"6","author":"Maejima","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/gm32","article-title":"Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome","volume":"1","author":"Griffin","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","article-title":"Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne muscular dystrophy aetiology","volume":"85","author":"Timpani","year":"2015","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ajpath.2025.11.002_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mus.25015","article-title":"Muscle damage, metabolism, and oxidative stress in mdx mice: impact of aerobic running","volume":"54","author":"Schill","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2025.11.002_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2217\/bmm-2019-0318","article-title":"Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer","volume":"14","author":"Mu","year":"2020","journal-title":"Biomark Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib31","article-title":"Therapeutic effect and mechanism of Bushen-Jianpi-Jiedu decoction combined with chemotherapeutic drugs on postoperative colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.11.002_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10020-019-0113-2","article-title":"Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer","volume":"25","author":"Zhou","year":"2019","journal-title":"Mol Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib34","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib35","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.ajpath.2025.11.002_bib36","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.11.002_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad415","article-title":"PyWGCNA: a Python package for weighted gene co-expression network analysis","volume":"39","author":"Rezaie","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.11.002_bib38","doi-asserted-by":"crossref","first-page":"W415","DOI":"10.1093\/nar\/gkae456","article-title":"WebGestalt 2024: faster gene set analysis and new support for metabolomics and multi-omics","volume":"52","author":"Elizarraras","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib39","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acs.jproteome.2c00651","article-title":"Cytoscape stringApp 2.0: analysis and visualization of heterogeneous biological networks","volume":"22","author":"Doncheva","year":"2023","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110371","article-title":"Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy","volume":"9","author":"Larcher","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.11.002_bib44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12933-025-02780-y","article-title":"Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy","volume":"24","author":"Arnold","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2025.11.002_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2025.11.002_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajpath.2025.11.002_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JND-170280","article-title":"Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database","volume":"4","author":"Koeks","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.ajpath.2025.11.002_bib49","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib50","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105415","article-title":"Single cell sequencing maps skeletal muscle cellular diversity as disease severity increases in dystrophic mouse models","volume":"25","author":"Saleh","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ajpath.2025.11.002_bib52","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.3390\/ijms23158735","article-title":"Characterisation of progressive skeletal muscle fibrosis in the Mdx mouse model of Duchenne muscular dystrophy: an in vivo and in vitro study","volume":"23","author":"Giovarelli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.11.002_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10522-024-10093-y","article-title":"The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKalpha\/MMP9\/TGF-beta1\/Smad pathway","volume":"25","author":"Huang","year":"2024","journal-title":"Biogerontology"},{"key":"10.1016\/j.ajpath.2025.11.002_bib54","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1210\/jc.2019-00706","article-title":"The effects of dapagliflozin on systemic and renal vascular function display an epigenetic signature","volume":"104","author":"Solini","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2025.11.002_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.121.001251","article-title":"Empagliflozin improves the microRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes","volume":"384","author":"Mone","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajpath.2025.11.002_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106591","article-title":"Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors","volume":"188","author":"Donniacuo","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib57","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/cells13070574","article-title":"Mitochondria and reactive oxygen species: the therapeutic balance of powers for Duchenne muscular dystrophy","volume":"13","author":"Casati","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2025.11.002_bib58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.00038.2012","article-title":"Exercise, GLUT4, and skeletal muscle glucose uptake","volume":"93","author":"Richter","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2025.11.002_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101620","article-title":"Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism","volume":"66","author":"Op den Kamp","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.ajpath.2025.11.002_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45390-y","article-title":"Empagliflozin induces the transcriptional program for nutrient homeostasis in skeletal muscle in normal mice","volume":"13","author":"Kawakami","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.11.002_bib61","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1113\/JP273185","article-title":"Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation","volume":"595","author":"Evans","year":"2017","journal-title":"J Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BCJ20210700","article-title":"Differential effect of canagliflozin, a sodium\u2013glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice","volume":"479","author":"Otsuka","year":"2022","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2025.11.002_bib63","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1073\/pnas.192571199","article-title":"Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle","volume":"99","author":"Haslett","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.11.002_bib64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2164-6-98","article-title":"Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling","volume":"6","author":"Turk","year":"2005","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ajpath.2025.11.002_bib65","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1074\/jbc.TM118.002812","article-title":"Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease","volume":"294","author":"Ito","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2025.11.002_bib66","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2025.11.002_bib67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nrm2024","article-title":"Molecular mechanisms of muscular dystrophies: old and new players","volume":"7","author":"Davies","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib68","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/s41401-024-01389-3","article-title":"SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization","volume":"45","author":"Lin","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ajpath.2025.11.002_bib69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ajpath.2025.11.002_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34305-x","article-title":"A reduced M1-like\/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition","volume":"8","author":"Miyachi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.11.002_bib72","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00011-023-01796-y","article-title":"SGLT2 inhibitors prevent LPS-induced M1 macrophage polarization and alleviate inflammatory bowel disease by downregulating NHE1 expression","volume":"72","author":"Kim","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.ajpath.2025.11.002_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2022.07.048","article-title":"Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role","volume":"367","author":"Fu","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O'Neill","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib75","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib76","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cmet.2018.09.018","article-title":"Fatty acid oxidation in macrophages and T cells: time for reassessment?","volume":"28","author":"Van den Bossche","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2025.11.002_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113947","article-title":"Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5\/6-nephrectomy","volume":"156","author":"Lu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajpath.2025.11.002_bib78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2025.11.002_bib79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2044-5040-1-21","article-title":"Aberrant repair and fibrosis development in skeletal muscle","volume":"1","author":"Mann","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.ajpath.2025.11.002_bib80","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fphys.2019.01074","article-title":"Fibro\u2013adipogenic progenitors cross-talk in skeletal muscle: the social network","volume":"10","author":"Biferali","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2025.11.002_bib81","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/4033","article-title":"Expression of full-length utrophin prevents muscular dystrophy in mdx mice","volume":"4","author":"Tinsley","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpath.2025.11.002_bib82","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/nan.12735","article-title":"Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies","volume":"47","author":"Soblechero-Martin","year":"2021","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294402500433X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294402500433X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:09:21Z","timestamp":1775178561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294402500433X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S000294402500433X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.11.002","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Skeletal Muscle in Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}